Search research articles
Contact Us
Filters
Showing results (211-220 of 236) with videos related to
Page
of 24
Sort By:
Journal for Immunotherapy of Cancer
|
October 20, 2019
Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors
Li Zhu, Jessica L Narloch, Sayali Onkar, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 2, 2025
Longitudinal ctDNA Surveillance in Older Women with ER+ Breast Cancer to Facilitate Surgical De-Escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies
Neil Carleton, Alexander C Chang, Fangyuan Chen, et al.
Biorxiv : the Preprint Server for Biology
|
March 27, 2026
Estrogen receptor-positive cell line xenograft models recapitulate metastatic dissemination and endocrine response of invasive lobular breast carcinoma
Nilgun Tasdemir, Laura Savariau, Julie Scott, et al.
Science Translational Medicine
|
March 28, 2014
Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancer
Thushangi N Pathiraja, Shweta R Nayak, Yuanxin Xi, et al.
Nature Communications
|
April 20, 2022
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation
Zheqi Li, Olivia McGinn, Yang Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2026
Use of ctDNA in Older Women with ER+ Breast Cancer to Facilitate Surgical De-escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies
Neil Carleton, Alexander C Chang, Fangyuan Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2015
Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients
Peilu Wang, Amir Bahreini, Rekha Gyanchandani, et al.
Oncogene
|
January 9, 2021
Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype
Damir Varešlija, Elspeth Ward, Siobhan P Purcell, et al.
Cancer Discovery
|
March 8, 2023
p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy
Douglas V Faget, Xianmin Luo, Matthew J Inkman, et al.
NPJ Breast Cancer
|
June 21, 2025
The MBCRC Advocate Researcher Program (MARP): connecting advocates and researchers as collaborative partners in cancer research
Hillary S Andrews, Igor L Bado, Amy Beumer, et al.
Page
of 24
Search research articles
Search
Showing results (211-220 of 236) with videos related to
Sort By:
Page
of 24
Journal for Immunotherapy of Cancer
|
October 20, 2019
Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors
Li Zhu, Jessica L Narloch, Sayali Onkar, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 2, 2025
Longitudinal ctDNA Surveillance in Older Women with ER+ Breast Cancer to Facilitate Surgical De-Escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies
Neil Carleton, Alexander C Chang, Fangyuan Chen, et al.
Biorxiv : the Preprint Server for Biology
|
March 27, 2026
Estrogen receptor-positive cell line xenograft models recapitulate metastatic dissemination and endocrine response of invasive lobular breast carcinoma
Nilgun Tasdemir, Laura Savariau, Julie Scott, et al.
Science Translational Medicine
|
March 28, 2014
Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancer
Thushangi N Pathiraja, Shweta R Nayak, Yuanxin Xi, et al.
Nature Communications
|
April 20, 2022
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation
Zheqi Li, Olivia McGinn, Yang Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2026
Use of ctDNA in Older Women with ER+ Breast Cancer to Facilitate Surgical De-escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies
Neil Carleton, Alexander C Chang, Fangyuan Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2015
Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients
Peilu Wang, Amir Bahreini, Rekha Gyanchandani, et al.
Oncogene
|
January 9, 2021
Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype
Damir Varešlija, Elspeth Ward, Siobhan P Purcell, et al.
Cancer Discovery
|
March 8, 2023
p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy
Douglas V Faget, Xianmin Luo, Matthew J Inkman, et al.
NPJ Breast Cancer
|
June 21, 2025
The MBCRC Advocate Researcher Program (MARP): connecting advocates and researchers as collaborative partners in cancer research
Hillary S Andrews, Igor L Bado, Amy Beumer, et al.
Page
of 24